JD Health International revenue and financials

6618 · HKEX · HKD

Compare JD Health International
$32.60Change from previous close: +0.56%Absolute change: +$0.18

Close · November 20, 2026

In the fiscal year ended December 2025, JD Health International reported revenue of ¥73.44B (+26.28% year over year). Net income was ¥5.38B, a net margin of 7.3%.

Annual revenue · 2025: ¥73.44B
  1. ¥5.55B2017
  2. ¥8.17B2018
  3. ¥10.84B2019
  4. ¥19.38B2020
  5. ¥30.68B2021
  6. ¥46.74B2022
  7. ¥53.53B2023
  8. ¥58.16B2024
  9. ¥73.44B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+26.28%
2025 vs 2024
Net income growth
+29.16%
2025 vs 2024
Net margin
7.3%
2024: 7.2%

How JD Health International is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of CNY; per-share values in CNY; shares in millions.

Income statement · Annual
Item202520242023202220212020201920182017
Total revenue73,44158,16053,53046,73630,68219,38310,8428,1695,553
Cost of revenue55,24244,85141,66536,84523,48514,4658,0306,1904,173
Gross profit18,19913,30911,8659,8927,1974,9172,8121,9791,380
Selling, general and administrative12,76710,81510,0088,9697,7083,9572,0421,4581,002
Research and development1,6341,3301,2261,067893609338218123
Operating income3,7981,163631-145-1,404352432303256
EBIT3,7981,163631-145-1,404352432303256
EBITDA3,9751,315795-60.9-1,372365437307258
Interest expense11.18.29.59.16.03.435.50.20.1
Pre-tax income6,0304,7972,693696-901-17,072-835306256
Income tax66364055031317116313791.377.4
Net income5,3754,1622,142380-1,074-17,234-972215179
Net income to common shareholders5,3754,1622,142380-1,074-17,234-972215179
Basic EPS1.701.320.690.12-0.35-7.80-0.45——
Diluted EPS1.681.320.680.12-0.35-7.80-0.45——
Average shares (basic)3,1633,1433,1243,1073,0952,2092,149——
Average shares (diluted)3,1963,1603,1643,1443,0952,2092,149——

Companies in the group: same and related industries, similar size